Evidence map›Paper›PMID 28535823›Full record

ArticleEpidemiology and infection2017

First report of the qnrA determinant in Shigella sonnei isolated from China.

H M Qian, T T Qin, G Y Liu, J Li, P Ma, X X Kong, B Gu, C J Bao

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology and infection, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

H M QianJiangsu Provincial Center for Disease Control and Prevention,Nanjing 210009,China.
T T QinMedical Technology School, Xuzhou Medical University,Xuzhou 221004,China.
G Y LiuMedical Technology School, Xuzhou Medical University,Xuzhou 221004,China.
J LiMedical Technology School, Xuzhou Medical University,Xuzhou 221004,China.
P MaMedical Technology School, Xuzhou Medical University,Xuzhou 221004,China.
X X KongJiangsu Provincial Center for Disease Control and Prevention,Nanjing 210009,China.
B GuMedical Technology School, Xuzhou Medical University,Xuzhou 221004,China.
C J BaoJiangsu Provincial Center for Disease Control and Prevention,Nanjing 210009,China.
Xuzhou Medical College · CNJiangsu Provincial Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the first presence of qnrA among Shigella sonnei clinical isolates in Jiangsu Province, China. The qnrA-positive isolates coexisted with the mutation in gyrA at codon 83, these isolates were resistant to nalidixic acid and 22·2% (2 of 9) of them were resistant to norfloxacin.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsChinaDrug Resistance, BacterialNalidixic AcidNorfloxacinShigella sonneiAnti-Bacterial AgentsBacterial ProteinsNalidixic AcidNorfloxacinChinafluoroquinolonesqnrAShigella sonnei

Identifiers

PMID28535823
PMCPMC9148851
OpenAlexW2617779504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.